Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients

NCT06211244 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.

NCT NCT06211244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients
Lead sponsor
Tungs' Taichung Metroharbour Hospital
Phase
Observational
Overall status
Completed
Start date
May 2, 2024
Completion date
December 31, 2024
Enrollment
291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, myocardium; injury